Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

toxicology · Mechanism Report

Can elevated urinary cadmium at age 71 reflect long-term retention?

Elevated urinary cadmium at age 71 can reflect cumulative long-term cadmium retention rather than only recent exposure.

PlausibleOctober 13, 202613 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Cadmium accumulates mainly in the kidneys and liver and has a biological half-life measured in decades, so elevated urinary cadmium at age 71 can reflect cumulative long-term retention rather than only a recent exposure.

laying out figure…
3 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says cadmium builds up mainly in the kidneys and liver and persists for decades in the body. The mechanism framing emphasizes chronic body burden as the main meaning of urinary cadmium, while also noting that kidney tubular injury can affect how directly the urine result reflects retained cadmium.

Verified conclusion

Cadmium is a persistent toxic metal whose toxicokinetics make a long exposure history highly relevant when interpreting urinary results in a 71-year-old woman.

Tissue retention and persistence

  • Human autopsy and toxicokinetic evidence identify the kidneys—especially renal cortex/proximal tubules—and liver as principal cadmium storage sites. Relative concentrations vary by population, smoking status, exposure history, and tissue compartment.
  • Cadmium’s biological half-life is measured in decades: conventionally about 10–30 years. Kidney-specific modeling has estimated 11.6 years (95% CI 10.1–14.7) in one analysis and as long as 45 years in another. These are model- and compartment-dependent estimates, but all support substantial long-term retention.

Mechanistic interpretation

  • Following absorption, cadmium is initially taken up in the liver, where it induces and binds metallothionein.
  • Cadmium–metallothionein complexes can circulate to the kidney, undergo glomerular filtration, and be reabsorbed by proximal tubular cells. Intracellular breakdown of the complex promotes renal cadmium retention.
  • The proximal tubule is also the main site of cadmium nephrotoxicity. Once tubular reabsorptive function is impaired, urinary cadmium may rise independently of total retained cadmium.

Clinical interpretation of urinary cadmium

  • Urinary cadmium is generally a biomarker of chronic cumulative exposure/body burden in low-to-moderate chronic exposure; therefore, an elevated value at age 71 can plausibly reflect exposures accumulated over much of life, not solely a recent source.
  • Recent exposure can contribute, but blood cadmium is generally the more responsive complementary marker for that question.
  • Interpretation should account for urine dilution, renal function, and proximal-tubular injury markers such as urinary β2-microglobulin or retinol-binding protein. In later life, tubular injury may make a single urinary value a less direct measure of lifetime retained burden.

Bottom line

  • The claim is well supported overall: renal and hepatic accumulation plus decades-long persistence mean elevated urinary cadmium at age 71 can reflect long-term cumulative retention, although kidney tubular status materially affects what the urinary result signifies.

References

  1. Is Chronic Kidney Disease Due to Cadmium Exposure Inevitable ... — pmc.ncbi.nlm.nih.gov ↗
  2. Metallothionein and Cadmium Toxicology—Historical Review ... — pmc.ncbi.nlm.nih.gov ↗
  3. Metallothionein Protection of Cadmium Toxicity - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  4. What Is the Biological Fate of Cadmium in the Body? - CDC Archive — archive.cdc.gov ↗
  5. Critical concentration of cadmium in kidney cortex of humans exposed to environmental cadmium - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  6. Population Toxicokinetic Modeling of Cadmium for Health Risk ... — pmc.ncbi.nlm.nih.gov ↗
  7. Physiologically-Based Toxicokinetic Model for Cadmium ... — pmc.ncbi.nlm.nih.gov ↗
  8. Cadmium Toxicity: Clinical Assessment - Laboratory Tests | ATSDR — archive.cdc.gov ↗
  9. 5.2. Urinary Cd Threshold... — pmc.ncbi.nlm.nih.gov ↗
  10. A State-of-the-Science Review on Metal Biomarkers - PMC — pmc.ncbi.nlm.nih.gov ↗
  11. _116N1_Science_1-89 — pmc.ncbi.nlm.nih.gov ↗
  12. AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY — archive.cdc.gov ↗
  13. Current Levels of Environmental Exposure to Cadmium in ... - PMC — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible12 sourcesDoes elevated urine gadolinium mean toxicity or symptom causation?→Plausible15 sourcesCan excess bismuth exposure cause neurotoxicity and kidney injury, and does elevated urine bismuth prove toxicity?→